Ken Fisher Explains What The Covid-19 Vaccine Means for Stocks

Positive COVID-19 vaccine developments are great news for the world. Promising vaccine developments can also benefit the global economy. However, positive vaccine developments may not always translate to optimism in the stock market. As Ken Fisher explains in this video, recent vaccine announcements won’t necessarily uplift stock prices as they are announced. Stocks are forward looking—usually looking about 3 to 30 months out—and pre-price widely known information. Therefore, stock prices likely already reflect the likelihood that we create and distribute COVID-19 vaccines within that 3-to-30 month timeframe. We view today’s news and developments on the vaccine front may not boost stocks as much as many believe.
We have seen this pre-pricing throughout the COVID-19 pandemic. COVID-19 news has been covered extensively, so stocks may have already priced in the probable outcomes, including vaccine developments. The stock market didn’t always know who was producing the vaccines, their efficacy or the details of production and rollout, but Ken Fisher believes the market has looked past the point where a vaccine is widely available. So, although vaccine developments are a great positive for our world, don’t let the current headlines significantly affect your decisions on stocks. The market might get short-term boosts from positive news, but they likely aren’t surprised by positive vaccine developments.
For more information on the COVID-19 pandemic and the impact on the stock market, visit Fisher Investments’ knowledge center: https://www.fisherinvestments.com/en-us/insights/coronavirus
Connect with us on: Facebook - https://www.facebook.com/FisherInvestments Twitter - https://twitter.com/fisherinvestLinkedIn - https://www.linkedin.com/company/fisher-investments

Видео Ken Fisher Explains What The Covid-19 Vaccine Means for Stocks канала Fisher Investments